✦ LIBER ✦

Properties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease

✍ Scribed by Lunkes, A.; Trottier, Y.; Fagart, J.; Schultz, P.; Zeder-Lutz, G.; Moras, D.; Mandel, J.-L.

Book ID: 120152763
Publisher: The Royal Society
Year: 1999
Tongue: English
Weight: 345 KB
Volume: 354
Category: Article
ISSN: 0080-4622
DOI: 10.1098/rstb.1999.0453

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel mechanism of Hsp70 chaperone-media

Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease

✍ Guzhova, I. V.; Lazarev, V. F.; Kaznacheeva, A. V.; Ippolitova, M. V.; Muronetz, 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 378 KB

Reduction of polyglutamine toxicity by T

Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models

✍ Tauffenberger, A.; Chitramuthu, B. P.; Bateman, A.; Bennett, H. P.; Parker, J. A 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 1022 KB

Ginsenosides protect striatal neurons in

Ginsenosides protect striatal neurons in a cellular model of Huntington's disease

✍ Jun Wu; Hye Kyoung Jeong; Sarah Elizabeth Bulin; Sung Won Kwon; Jeong Hill Park; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

## Abstract Ginseng, the root of __Panax ginseng__ C.A. Meyer (Araliaceae), is a widely used herbal medicine. Ginsenosides, the active ingredients of ginseng, are the main components responsible for many beneficial actions of ginseng. In the present study, we tested 10 different ginsenosides in the

Changes in the store-dependent calcium i

Changes in the store-dependent calcium influx in a cellular model of Huntington’s disease

✍ L. N. Glushankova; O. A. Zimina; V. A. Vigont; G. N. Mozhaeva; I. B. Bezprozvann 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 314 KB

Cystamine increases l-cysteine levels in

Cystamine increases l-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation

✍ Jonathan H. Fox; David S. Barber; Bhupinder Singh; Birgit Zucker; Mary K. Swinde 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

Targeting aggregation in the development

Targeting aggregation in the development of therapeutics for the treatment of Huntington’s disease and other polyglutamine repeat diseases

✍ Steffan, Joan S; Thompson, Leslie Michels 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 198 KB